---
author: []
related: []
publisher:
  url: 'http://www.metabolostasis.com'
  name: MetaboloStasis Therapeutics
  favicon: 'http://nebula.phx3.secureserver.net/c6714f9bd306e3c0b2c809a982b77815?AccessKeyId=A0CE1EF33ABC5529819D&disposition=0&alloworigin=1'
  domain: www.metabolostasis.com
keywords:
  - therapeutics
  - metabolostasis
  - disorders
  - exomeseq
  - copper
  - sequencing
  - genes
  - disease
  - metabolic
  - deficiency
description: 'METABOLOSTASIS THERAPEUTICS is committed to the development of novel therapeutics for the treatment of rare diseases. Current research focuses on disorders of copper metabolism, an essential micro-nutrient whose deficiency or excess leads to immune dysfunction, heart disease, tumor development as well as dramatic neurodegeneration.'
inLanguage: en
app_links: []
isBasedOnUrl: 'http://www.metabolostasis.com/'
title: Home
datePublished: '2015-12-19T21:41:26.899Z'
dateModified: '2015-12-19T21:13:56.204Z'
sourcePath: _posts/2015-12-19-home.md
published: true
inFeed: true
hasPage: false
inNav: false
_context: 'http://schema.org'
_type: MediaObject

---
<article style=""><h1>Home</h1><p>METABOLOSTASIS THERAPEUTICS is committed to the development of novel therapeutics for the treatment of rare diseases&amp;period; Current research focuses on disorders of copper metabolism&amp;comma; an essential micro-nutrient whose deficiency or excess leads to immune dysfunction&amp;comma; heart disease&amp;comma; tumor development as well as dramatic neurodegeneration&amp;period;</p><img src="http://nebula.wsimg.com/9bef6df0c076479198e0af6d971d8889?AccessKeyId=A0CE1EF33ABC5529819D&amp;disposition=0&amp;alloworigin=1" /></article>